NO975136D0 - Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin - Google Patents
Farmasöytisk blanding omfattende Lactobacillus plantarum og argininInfo
- Publication number
- NO975136D0 NO975136D0 NO975136A NO975136A NO975136D0 NO 975136 D0 NO975136 D0 NO 975136D0 NO 975136 A NO975136 A NO 975136A NO 975136 A NO975136 A NO 975136A NO 975136 D0 NO975136 D0 NO 975136D0
- Authority
- NO
- Norway
- Prior art keywords
- arginine
- pharmaceutical composition
- lactobacillus plantarum
- composition
- curative
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title abstract 2
- 240000006024 Lactobacillus plantarum Species 0.000 title abstract 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010070545 Bacterial translocation Diseases 0.000 abstract 1
- 206010019663 Hepatic failure Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000007375 bacterial translocation Effects 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 231100000753 hepatic injury Toxicity 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 210000004347 intestinal mucosa Anatomy 0.000 abstract 1
- 231100000835 liver failure Toxicity 0.000 abstract 1
- 208000007903 liver failure Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9501719A SE9501719D0 (sv) | 1995-05-09 | 1995-05-09 | Pharmaceutical composition |
| PCT/SE1996/000603 WO1996035440A1 (en) | 1995-05-09 | 1996-05-08 | Pharmaceutical composition comprising lactobacillus plantarum and arginine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO975136L NO975136L (no) | 1997-11-07 |
| NO975136D0 true NO975136D0 (no) | 1997-11-07 |
| NO317668B1 NO317668B1 (no) | 2004-11-29 |
Family
ID=20398250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19975136A NO317668B1 (no) | 1995-05-09 | 1997-11-07 | Farmasoytisk blanding omfattende Lactobacillus plantarum og arginin, samt anvendelse derav |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0825869B1 (no) |
| JP (1) | JP4058560B2 (no) |
| KR (1) | KR19990008403A (no) |
| CN (1) | CN1152678C (no) |
| AT (1) | ATE221783T1 (no) |
| AU (1) | AU704886B2 (no) |
| BR (1) | BR9608284A (no) |
| CA (1) | CA2220498A1 (no) |
| DE (2) | DE825869T1 (no) |
| EE (1) | EE03597B1 (no) |
| ES (1) | ES2112818T3 (no) |
| GR (1) | GR980300028T1 (no) |
| NO (1) | NO317668B1 (no) |
| PL (1) | PL184603B1 (no) |
| SE (1) | SE9501719D0 (no) |
| WO (1) | WO1996035440A1 (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100376954B1 (ko) * | 1995-07-31 | 2003-07-18 | 프로비 에이비 | 장에서집락화하는유산간균 |
| BR0109496A (pt) | 2000-03-24 | 2002-12-10 | Nestle Sa | Uso de bactéria do ácido láctico para o tratamento de peritonite |
| KR100585391B1 (ko) * | 2002-01-24 | 2006-06-01 | 주식회사 프로바이오닉 | 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제 |
| SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
| US20070224285A1 (en) | 2004-03-31 | 2007-09-27 | Calpis Co., Ltd | Agent for Preventing or Suppressing Hepatopathy and Functional Food for Preventing or Suppressing Hepatopathy |
| KR100592717B1 (ko) * | 2004-11-20 | 2006-06-26 | 주식회사 알엔에이 | 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물 |
| CN1322111C (zh) * | 2004-12-17 | 2007-06-20 | 上海交大昂立股份有限公司 | 一种植物乳杆菌 |
| CN100337653C (zh) * | 2004-12-21 | 2007-09-19 | 上海交大昂立股份有限公司 | 一种含有植物乳杆菌的组合物 |
| AU2006296837B2 (en) * | 2005-09-28 | 2012-12-13 | Nordic Rebalance A/S | Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors |
| JP5413819B2 (ja) * | 2008-02-08 | 2014-02-12 | 国立大学法人広島大学 | 肝機能改善剤およびその製造用ツール、ならびにこれらの利用 |
| JP5823695B2 (ja) * | 2008-12-03 | 2015-11-25 | 国立大学法人広島大学 | 肝機能障害予防剤 |
| KR101075558B1 (ko) * | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101075557B1 (ko) * | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101255050B1 (ko) | 2009-07-14 | 2013-04-16 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101486999B1 (ko) * | 2009-07-22 | 2015-01-28 | 씨제이제일제당 주식회사 | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| CN102618456B (zh) * | 2012-02-28 | 2013-08-21 | 江南大学 | 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途 |
| TWI463986B (zh) * | 2012-08-29 | 2014-12-11 | Univ China Medical | 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途 |
| JP7136807B2 (ja) | 2017-04-17 | 2022-09-13 | ザ・ユニバーシティ・オブ・シカゴ | ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料 |
| MX2024006840A (es) * | 2021-12-09 | 2024-06-19 | Nestle Sa | Lactobacillus acidophilus para aumentar la produccion de agmatina mediante la microbiota. |
-
1995
- 1995-05-09 SE SE9501719A patent/SE9501719D0/xx unknown
-
1996
- 1996-05-08 BR BR9608284A patent/BR9608284A/pt not_active IP Right Cessation
- 1996-05-08 AU AU57846/96A patent/AU704886B2/en not_active Ceased
- 1996-05-08 DE DE0825869T patent/DE825869T1/de active Pending
- 1996-05-08 WO PCT/SE1996/000603 patent/WO1996035440A1/en active IP Right Grant
- 1996-05-08 JP JP53399796A patent/JP4058560B2/ja not_active Expired - Fee Related
- 1996-05-08 CA CA002220498A patent/CA2220498A1/en not_active Abandoned
- 1996-05-08 EP EP96914505A patent/EP0825869B1/en not_active Expired - Lifetime
- 1996-05-08 CN CNB961953993A patent/CN1152678C/zh not_active Expired - Fee Related
- 1996-05-08 AT AT96914505T patent/ATE221783T1/de not_active IP Right Cessation
- 1996-05-08 ES ES96914505T patent/ES2112818T3/es not_active Expired - Lifetime
- 1996-05-08 DE DE69622855T patent/DE69622855T2/de not_active Expired - Fee Related
- 1996-05-08 PL PL96323320A patent/PL184603B1/pl not_active IP Right Cessation
- 1996-05-08 EE EE9700269A patent/EE03597B1/xx not_active IP Right Cessation
- 1996-05-08 KR KR1019970707930A patent/KR19990008403A/ko not_active Application Discontinuation
-
1997
- 1997-11-07 NO NO19975136A patent/NO317668B1/no not_active Application Discontinuation
-
1998
- 1998-04-30 GR GR980300028T patent/GR980300028T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11504936A (ja) | 1999-05-11 |
| CN1190346A (zh) | 1998-08-12 |
| AU704886B2 (en) | 1999-05-06 |
| EE03597B1 (et) | 2002-02-15 |
| ES2112818T1 (es) | 1998-04-16 |
| CN1152678C (zh) | 2004-06-09 |
| EP0825869A1 (en) | 1998-03-04 |
| DE69622855T2 (de) | 2003-04-10 |
| CA2220498A1 (en) | 1996-11-14 |
| DE69622855D1 (de) | 2002-09-12 |
| GR980300028T1 (en) | 1998-04-30 |
| ATE221783T1 (de) | 2002-08-15 |
| SE9501719D0 (sv) | 1995-05-09 |
| EE9700269A (et) | 1998-04-15 |
| NO975136L (no) | 1997-11-07 |
| EP0825869B1 (en) | 2002-08-07 |
| KR19990008403A (ko) | 1999-01-25 |
| ES2112818T3 (es) | 2003-02-16 |
| BR9608284A (pt) | 1999-06-08 |
| DE825869T1 (de) | 1998-07-16 |
| PL184603B1 (pl) | 2002-11-29 |
| PL323320A1 (en) | 1998-03-16 |
| WO1996035440A1 (en) | 1996-11-14 |
| NO317668B1 (no) | 2004-11-29 |
| AU5784696A (en) | 1996-11-29 |
| JP4058560B2 (ja) | 2008-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO975136L (no) | Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin | |
| HUP0200206A2 (hu) | Tejsavbaktérium-törzsek hasmenés megelőzésére | |
| SE9702083D0 (sv) | Farmaceutisk beredning för bekämpning av patogena tarmbakterier | |
| DE69839993D1 (de) | Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids | |
| GR3026758T3 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
| TR200101699T2 (tr) | Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması | |
| HUP0200205A2 (hu) | Tejsavbaktérium-törzsek hasmenés megelőzésére | |
| HUP0203185A2 (hu) | Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| CA2091557A1 (en) | Intestine colonizing lactobacilli | |
| HUP9901707A2 (hu) | Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények | |
| ES2074698T3 (es) | Composicion oral para el tratamiento de enfermedades intestinales inflamatorias. | |
| WO2002083879A3 (en) | Immunotherapy based on dendritic cells | |
| WO1998035658A3 (de) | Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon | |
| ZA947894B (en) | Compounds for medicinal use | |
| JPS6483025A (en) | Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent | |
| RU2072692C1 (ru) | Штамм бактерий lactobacillus helveticus, обладающий способностью снижать уровень холестерина в крови и используемый для получения препаратов и продуктов питания для профилактики и лечения гиперхолестеринемий | |
| AU4630700A (en) | Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof | |
| Garg | Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications | |
| UA30011A (uk) | Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань | |
| UA31364A (uk) | Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит | |
| IT1274733B (it) | Ceppo del genere lactobacillus di origine umana e suoi usi | |
| BG49408A1 (en) | Medicationad premix | |
| UA10219A (uk) | Спосіб лікування туберкульозу легень |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |